Literature DB >> 20074341

Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: a case report.

Natalia Mejia-Gaviria1, Helena Gil-Peña, Eliecer Coto, Teresa M Pérez-Menéndez, Fernando Santos.   

Abstract

Hereditary hypophosphatemic rickets with hypercalciuria is a rare autosomal recessive disorder (OMIM #241530), characterized by decreased renal phosphate reabsorption that leads to hypophosphatemia, rickets, and bone pain; hypophosphatemia is believed to stimulate 1,25 dihydroxyvitamin D synthesis which, in turn, results in hypercalciuria. Hereditary hypophosphatemic rickets with hypercalciuria is caused by loss-of-function in the type 2c sodium phosphate cotransporter encoded by the SLC34A3 gene. This report shows a family with a non-previously identified mutation in the SLC34A3 gene and exhibiting mild and different manifestations of HHRH. The probandus had hypophosphatemia, elevated serum 1,25 dihydroxyvitamin D concentrations, high serum alkaline phosphatase levels, hypercalciuria and nephrocalcinosis. The other members of the family presented some of these alterations: the mother, hypercalciuria and high 1,25 dihydroxyvitamin D concentrations; the son, hypercalciuria, high 1,25 dihydroxyvitamin D values and elevated alkaline phosphatases; the father, high alkaline phosphatases. The genetic analysis revealed the existence of a single mutation (G78R) in heterozygosis in the SLC34A3 gene in the probandus, her mother and her brother, but not in the father. These findings suggest that he mutation in heterozygosis likely gave rise to a mild phenotype with different penetrance in the three relatives and also indicates that the elevation of 1,25 dihydroxyvitamin D does not result from hypophosphatemia. Thus, this family raises some issues on the transmission and pathophysiology of hereditary hypophosphatemic rickets with hypercalciuria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074341      PMCID: PMC2821378          DOI: 10.1186/1750-1172-5-1

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  16 in total

1.  Growth-related renal type II Na/Pi cotransporter.

Authors:  Hiroko Segawa; Ichiro Kaneko; Akira Takahashi; Masashi Kuwahata; Mikiko Ito; Ichiro Ohkido; Sawako Tatsumi; Ken-Ichi Miyamoto
Journal:  J Biol Chem       Date:  2002-03-05       Impact factor: 5.157

Review 2.  Proximal tubular phosphate reabsorption: molecular mechanisms.

Authors:  H Murer; N Hernando; I Forster; J Biber
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

3.  [Idiopathic hypercalciuria with nanism and renal involvement in children].

Authors:  P ROYER; H MATHIEU; S GERBEAUX; A FREDERICH; J RODRIGUEZ-SORIANO; A M DARTOIS; P CUISINIER
Journal:  Ann Pediatr (Paris)       Date:  1962-03-02

4.  "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect.

Authors:  M Tieder; D Modai; U Shaked; R Samuel; R Arie; A Halabe; J Maor; J Weissgarten; Z Averbukh; N Cohen
Journal:  N Engl J Med       Date:  1987-01-15       Impact factor: 91.245

5.  Nomogram for derivation of renal threshold phosphate concentration.

Authors:  R J Walton; O L Bijvoet
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

6.  Inherited elevation of alkaline phosphatase activity in the absence of disease.

Authors:  J W Wilson
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

7.  Hereditary hypophosphatemic rickets with hypercalciuria.

Authors:  M Tieder; D Modai; R Samuel; R Arie; A Halabe; I Bab; D Gabizon; U A Liberman
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

8.  SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.

Authors:  Clemens Bergwitz; Nicole M Roslin; Martin Tieder; J C Loredo-Osti; Murat Bastepe; Hilal Abu-Zahra; Danielle Frappier; Kelly Burkett; Thomas O Carpenter; Donald Anderson; Michele Garabedian; Isabelle Sermet; T Mary Fujiwara; Kenneth Morgan; Harriet S Tenenhouse; Harald Juppner
Journal:  Am J Hum Genet       Date:  2005-12-09       Impact factor: 11.025

9.  Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.

Authors:  Bettina Lorenz-Depiereux; Anna Benet-Pages; Gertrud Eckstein; Yardena Tenenbaum-Rakover; Janine Wagenstaller; Dov Tiosano; Ruth Gershoni-Baruch; Norbert Albers; Peter Lichtner; Dirk Schnabel; Ze'ev Hochberg; Tim M Strom
Journal:  Am J Hum Genet       Date:  2005-12-09       Impact factor: 11.025

10.  Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications.

Authors:  B Kremke; C Bergwitz; W Ahrens; S Schütt; M Schumacher; V Wagner; P-M Holterhus; H Jüppner; O Hiort
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-06-03       Impact factor: 2.949

View more
  13 in total

1.  Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.

Authors:  Y Yu; S R Sanderson; M Reyes; A Sharma; N Dunbar; T Srivastava; H Jüppner; C Bergwitz
Journal:  Bone       Date:  2012-02-24       Impact factor: 4.398

2.  Intronic deletions in the SLC34A3 gene: a cautionary tale for mutation analysis of hereditary hypophosphatemic rickets with hypercalciuria.

Authors:  Shoji Ichikawa; Shamir Tuchman; Leah R Padgett; Amie K Gray; H Jorge Baluarte; Michael J Econs
Journal:  Bone       Date:  2013-10-29       Impact factor: 4.398

Review 3.  Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

Authors:  Carsten A Wagner; Isabel Rubio-Aliaga; Nati Hernando
Journal:  Pediatr Nephrol       Date:  2017-12-23       Impact factor: 3.714

Review 4.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

Review 5.  Hypophosphatemia and growth.

Authors:  Fernando Santos; Rocío Fuente; Natalia Mejia; Laura Mantecon; Helena Gil-Peña; Flor A Ordoñez
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

6.  Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.

Authors:  Debayan Dasgupta; Mark J Wee; Monica Reyes; Yuwen Li; Peter J Simm; Amita Sharma; Karl-Peter Schlingmann; Marco Janner; Andrew Biggin; Joanna Lazier; Michaela Gessner; Dionisios Chrysis; Shamir Tuchman; H Jorge Baluarte; Michael A Levine; Dov Tiosano; Karl Insogna; David A Hanley; Thomas O Carpenter; Shoji Ichikawa; Bernd Hoppe; Martin Konrad; Lars Sävendahl; Craig F Munns; Hang Lee; Harald Jüppner; Clemens Bergwitz
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

Review 7.  Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.

Authors:  Clemens Bergwitz; Ken-Ichi Miyamoto
Journal:  Pflugers Arch       Date:  2018-08-14       Impact factor: 3.657

8.  Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.

Authors:  Johanna Korvala; Harald Jüppner; Outi Mäkitie; Etienne Sochett; Dirk Schnabel; Stefano Mora; Cynthia F Bartels; Matthew L Warman; Donald Deraska; William G Cole; Heini Hartikka; Leena Ala-Kokko; Minna Männikkö
Journal:  BMC Med Genet       Date:  2012-04-10       Impact factor: 2.103

9.  New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis.

Authors:  Sibylle Sabrautzki; Isabel Rubio-Aliaga; Wolfgang Hans; Helmut Fuchs; Birgit Rathkolb; Julia Calzada-Wack; Christian M Cohrs; Matthias Klaften; Hartwig Seedorf; Sebastian Eck; Ana Benet-Pagès; Jack Favor; Irene Esposito; Tim M Strom; Eckhard Wolf; Bettina Lorenz-Depiereux; Martin Hrabě de Angelis
Journal:  Mamm Genome       Date:  2012-04-21       Impact factor: 2.957

10.  DMP1 C-terminal mutant mice recapture the human ARHR tooth phenotype.

Authors:  Baichun Jiang; Zhengguo Cao; Yongbo Lu; Carol Janik; Stephanie Lauziere; Yixia Xie; Anne Poliard; Chunlin Qin; Leanne M Ward; Jian Q Feng
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.